The best treatments for PTSD are trauma-focused psychotherapies, specifically Cognitive Processing Therapy (CPT), Prolonged Exposure (PE), and Eye Movement Desensitization and Reprocessing (EMDR). All three are strongly recommended by the 2023 VA/DoD Clinical Practice Guideline, which represents the most current evidence-based standard of care. Medications can also help, but therapy that directly addresses the traumatic memory tends to produce the most lasting improvement.
That said, “best” depends partly on you. People respond differently to different approaches, and the treatment that works is often the one you’re willing to fully engage with. Here’s what each option involves so you can make an informed choice.
Cognitive Processing Therapy (CPT)
CPT works on the idea that PTSD persists because of how your mind has made sense of what happened. After a traumatic event, people often develop beliefs that are understandable but inaccurate or overly broad: “It was my fault,” “I can never be safe,” “I can’t trust anyone.” In CPT, these are called “stuck points,” and they’re the core target of treatment.
Over roughly 12 weekly sessions of about 60 minutes each, a therapist uses a guided questioning style to help you identify these stuck points and examine whether they hold up. You’ll also complete daily worksheets between sessions that walk you through challenging these beliefs on your own. The goal isn’t to minimize what happened but to help you integrate the trauma into a more balanced understanding of yourself and the world. People who already like writing or journaling sometimes gravitate toward CPT because it involves a fair amount of structured written work. If your symptoms improve quickly, treatment can wrap up in as few as 10 sessions.
Prolonged Exposure (PE)
PE targets avoidance, which is the engine that keeps PTSD running. When you avoid reminders of a trauma, whether that’s places, people, conversations, or even your own memories, the fear never gets a chance to decrease on its own. PE systematically reverses that pattern through two types of exposure.
The first is in vivo exposure: gradually and repeatedly approaching real-world situations you’ve been avoiding that are objectively safe. That might mean driving past a location, going to a crowded store, or sitting in a parked car at night. The second is imaginal exposure: recounting the traumatic memory aloud in session, focusing on the thoughts and feelings you had at the time, and repeating this across sessions until the memory loses its intensity.
The standard PE protocol runs 9 to 12 sessions, each lasting 90 to 120 minutes (longer than CPT sessions). Some people need a few additional sessions. PE tends to appeal to people who feel intuitively that they need to talk through what happened. The first few sessions of imaginal exposure can feel intense, but distress typically decreases both within and between sessions as your brain learns that the memory itself is not dangerous.
EMDR
EMDR involves recalling distressing trauma-related images, thoughts, and body sensations while simultaneously following a side-to-side stimulus, usually the therapist’s moving finger or a light bar. The bilateral stimulation is thought to help the brain reprocess traumatic memories so they become less emotionally charged.
EMDR is recommended alongside CPT and PE by major clinical guidelines, and head-to-head research shows both EMDR and trauma-focused cognitive behavioral therapies produce large reductions in PTSD symptoms. A meta-analysis found trauma-focused CBT (like CPT and PE) was marginally more effective than EMDR in children and adolescents, though a direct randomized trial found no statistically significant difference between the two. In practice, the gap is small enough that individual fit matters more than picking a “winner.”
One thing worth knowing: in clinical settings, EMDR is sometimes presented more briefly or with a vaguer rationale than CPT or PE, which can make it harder to evaluate. Research on patient decision-making found that when providers described EMDR with less enthusiasm or clarity, patients chose it less often, not because of the evidence but because of how it was framed. If EMDR interests you, it’s worth asking a provider to walk you through the rationale in detail.
Medications That Help
Only two medications are FDA-approved specifically for PTSD: sertraline (Zoloft) and paroxetine (Paxil), both SSRIs that increase serotonin activity in the brain. A third medication, venlafaxine (Effexor), is strongly recommended by VA/DoD guidelines based on large clinical trials, even though it doesn’t carry a formal FDA approval for PTSD. All three work by gradually reducing the intensity of PTSD symptoms like hypervigilance, emotional numbness, and intrusive thoughts.
Medication is often used alongside therapy rather than as a replacement for it. For some people, starting an SSRI can take the edge off enough to make engaging in trauma-focused therapy possible. For others who can’t access or aren’t ready for therapy, medication alone provides meaningful symptom relief.
Prazosin for Nightmares
Trauma-related nightmares are one of the most disruptive PTSD symptoms, and they don’t always respond well to SSRIs. Prazosin, a blood pressure medication that blocks the stress chemical norepinephrine, has shown consistent effectiveness in reducing the frequency and intensity of PTSD-related nightmares and improving overall sleep quality across multiple placebo-controlled studies. It’s typically taken at bedtime and is considered a targeted add-on for this specific symptom cluster.
Newer Approaches Still Under Review
MDMA-assisted therapy has generated significant attention as a potential treatment for PTSD that hasn’t responded to standard options. The protocol developed by Lykos Therapeutics involves twelve 90-minute therapy sessions plus three longer medicine sessions lasting 6 to 8 hours each. Two phase 3 randomized controlled trials showed that participants who received MDMA alongside therapy had significantly greater reductions in PTSD symptoms compared to those who received therapy with a placebo, with large effect sizes.
MDMA remains a Schedule I substance with no currently approved medical use. The FDA is reviewing the evidence, which could eventually lead to rescheduling and approval. For now, it’s not available outside of clinical trials, and the existing research has limited representation of certain populations, including military veterans, who made up only about 19% of each phase 3 trial sample.
Stellate ganglion block (SGB), an injection of local anesthetic near a nerve cluster in the neck, has also drawn interest. Uncontrolled case series reported rapid improvement in 70% to 75% of recipients, mostly active-duty military with combat-related PTSD. However, a randomized controlled trial found that SGB produced only 5% to 15% improvement after one round, which was no better than a saline injection. Long-term durability is also unclear, as most follow-up has been limited to three months. The evidence isn’t strong enough to recommend it as a standard treatment.
How to Choose the Right Treatment
Research on how people actually make PTSD treatment decisions reveals something important: most people don’t deliberate extensively. They hear a description and have a gut reaction. Someone who values journaling leans toward CPT. Someone who feels they need to “talk about it” picks PE. Someone drawn to a less verbal approach gravitates toward EMDR. These instincts aren’t irrational. Engagement matters enormously in trauma therapy, and a treatment you’re motivated to complete will generally outperform one you dread or drop out of.
Trust in your provider also plays a larger role than many people expect. Studies on patient decision-making found that some people felt more confident in their treatment choice because they trusted their therapist than because of any specific feature of the treatment itself. Finding a provider you feel comfortable with, especially one who can clearly explain the options and seems genuinely knowledgeable about more than one approach, is a practical step that directly affects outcomes.
The factors that matter most when choosing are: what the treatment involves day to day, how long it takes, what side effects or discomfort to expect, and how long the benefits last. All three first-line therapies have strong evidence. The “best” one is the one you’ll show up for, do the homework for, and see through to completion.